Structure-Based Optimization and Biological Evaluation of Pancreatic Lipase Inhibitors as Novel Potential Antiobesity Agents

doi:10.1007/s13659-015-0062-6

应用天然产物 ›› 2015, Vol. 5 ›› Issue (3): 129-157.DOI: 10.1007/s13659-015-0062-6

Structure-Based Optimization and Biological Evaluation of Pancreatic Lipase Inhibitors as Novel Potential Antiobesity Agents

Kun Wei¹, Gang-Qiang Wang^1,2, Xue Bai¹, Yan-Fen Niu¹, He-Ping Chen¹, Chun-Nan Wen¹, Zheng-Hui Li¹, Ze-Jun Dong¹, Zhi-Li Zuo¹, Wen-Yong Xiong¹, Ji-Kai Liu¹

1. State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China;
2. School of Nuclear Technology and Chemistry & Biology, Hubei University of Science and Technology, Xianning 437100, China

收稿日期:2015-04-21 修回日期:2015-05-20 出版日期:2015-06-24 发布日期:2018-02-11
基金资助:
The authors are grateful to the National Natural Science Foundation of China(81102348, U1132607, 81373289).

Structure-Based Optimization and Biological Evaluation of Pancreatic Lipase Inhibitors as Novel Potential Antiobesity Agents

Kun Wei¹, Gang-Qiang Wang^1,2, Xue Bai¹, Yan-Fen Niu¹, He-Ping Chen¹, Chun-Nan Wen¹, Zheng-Hui Li¹, Ze-Jun Dong¹, Zhi-Li Zuo¹, Wen-Yong Xiong¹, Ji-Kai Liu¹

1. State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China;
2. School of Nuclear Technology and Chemistry & Biology, Hubei University of Science and Technology, Xianning 437100, China

Received:2015-04-21 Revised:2015-05-20 Online:2015-06-24 Published:2018-02-11
Supported by:
The authors are grateful to the National Natural Science Foundation of China(81102348, U1132607, 81373289).

摘要/Abstract

摘要： The unusual fused β-lactone vibralactone was isolated from cultures of the basidiomycete Boreostereum vibrans and has been shown to significantly inhibit pancreatic lipase. In this study, a structure-based lead optimization of vibralactone resulted in three series of 104 analogs, among which compound C1 exhibited the most potent inhibition of pancreatic lipase, with an IC₅₀ value of 14 nM. This activity is more than 3000-fold higher than that of vibralactone. The effect of compound C1 on obesity was investigated using high-fat diet(HFD)-induced C57BL/6 J obese mice. Treatment with compound C1 at a dose of 100 mg/kg significantly decreased HFD-induced obesity, primarily through the improvement of metabolic parameters, such as triglyceride levels.

关键词: Natural products, Structure optimization, Antiobesity agents, Pancreatic lipase inhibitors, Vibralactone derivatives

Abstract: The unusual fused β-lactone vibralactone was isolated from cultures of the basidiomycete Boreostereum vibrans and has been shown to significantly inhibit pancreatic lipase. In this study, a structure-based lead optimization of vibralactone resulted in three series of 104 analogs, among which compound C1 exhibited the most potent inhibition of pancreatic lipase, with an IC₅₀ value of 14 nM. This activity is more than 3000-fold higher than that of vibralactone. The effect of compound C1 on obesity was investigated using high-fat diet(HFD)-induced C57BL/6 J obese mice. Treatment with compound C1 at a dose of 100 mg/kg significantly decreased HFD-induced obesity, primarily through the improvement of metabolic parameters, such as triglyceride levels.

Key words: Natural products, Structure optimization, Antiobesity agents, Pancreatic lipase inhibitors, Vibralactone derivatives

Kun Wei, Gang-Qiang Wang, Xue Bai, Yan-Fen Niu, He-Ping Chen, Chun-Nan Wen, Zheng-Hui Li, Ze-Jun Dong, Zhi-Li Zuo, Wen-Yong Xiong, Ji-Kai Liu. Structure-Based Optimization and Biological Evaluation of Pancreatic Lipase Inhibitors as Novel Potential Antiobesity Agents[J]. 应用天然产物, 2015, 5(3): 129-157.

参考文献

1. S.A. Tucci, E.J. Boyland, J.C.G. Halford, Diabetes Metab. Syndr. Obes. 3, 125-143 (2010)
2. C.J. Stein, G.A. Colditz, J. Clin. Endocrinol. Metab. 89, 2522-2525 (2004)
3. G.A. Bray, J. Clin. Endocrinol. Metab. 89, 2583-2589 (2004)
4. A.H. Mokdad, E.S. Ford, B.A. Bowman, W.H. Dietz, F. Vinicor, V.S. Bales, J.S. Marks, J. Am. Med. Assoc. 289, 76-79 (2003)
5. R.B. Birari, K.K. Bhutani, Drug Discov. Today 12, 879-889 (2007)
6. L.A. Campfield, F.J. Smith, P. Burn, Science 280, 1383-1387 (1998)
7. M.K. Badman, J.S. Flier, Science 307, 1909-1914 (2005)
8. A.L. De la Garza, F.I. Milagro, N. Boque, J. Campion, A. Martinez, Planta Med. 77, 773-785 (2011)
9. J.H. Ahn, Q. Liu, C. Lee, M.J. Ahn, H.S. Yoo, B.Y. Hwang, M.K.A. Lee, Bioorg. Med. Chem. Lett. 22, 2760-2763 (2012)
10. K.V. Sachidhara, M. Kumar, R. Sonkar, R. Sonkar, B.S. Singh, A.K. Khanna, G. Bhatia, J. Med. Chem. 55, 2769-2779 (2012)
11. H.E. Bays, K.M. Gadde, Drugs Today 47, 903-914 (2011)
12. J.Y. Chen, Y.Z. Pu, H.Y. Pei, L.H. He, S.H. Fu, L.J. Chen, Arch. Pharm. Chem. Life Sci. 347, 908-922 (2014)
13. L.H. He, H.Y. Pei, L. Ma, Y.Z. Pu, J.Y. Chen, Z.W. Liu, Y. Ran, L. Lei, M.H. Tang, A.H. Peng, C.F. Long, Eur. J. Med. Chem. 87, 595-610 (2014)
14. R.D. Richardson, G. Ma, Y. Oyola, M. Zancanella, L.M. Knowles, P. Cieplak, D. Romo, J.W. Smith, J. Med. Chem. 51, 5285-5296 (2008)
15. D.Z. Liu, F. Wang, T.G. Liao, J.G. Tang, W. Steglich, H.J. Zhu, J.K. Liu, Org. Lett. 8, 5749-5752 (2006)
16. M.Y. Jiang, F. Wang, X.L. Yang, L.Z. Fang, Z.J. Dong, H.J. Zhu, J.K. Liu, Chem. Pharm. Bull. 56, 1286-1288 (2008)
17. M.Y. Jiang, L. Zhang, Z.J. Dong, Z.L. Yang, Y. Leng, J.K. Liu, Chem. Pharm. Bull. 58, 113-116 (2010)
18. G.Q. Wang, K. Wei, T. Feng, Z.H. Li, L. Zhang, Q.A. Wang, J.K. Liu, J. Asian Nat. Prod. Res. 14, 115-120 (2012)
19. J.H. Ding, T. Feng, Z.H. Li, L. Li, J.K. Liu, Nat. Prod. Bioprospect. 2, 200-205 (2012)
20. G.Q. Wang, K. Wei, Z.H. Li, T. Feng, J.H. Ding, Q.A. Wang, J.K. Liu, J. Asian Nat. Prod. Res. 15, 950-955 (2013)
21. H.P. Chen, Z.Z. Zhao, R.H. Yin, X. Yin, T. Feng, Z.H. Li, K. Wei, J.K. Liu, Nat. Prod. Bioprospect. 4, 271-276 (2014)
22. G.Q. Wang, K. Wei, L. Zhang, Z.H. Li, Q.A. Wang, J.K. Liu, J. Asian Nat. Prod. Res. 16, 447-452 (2014)
23. Q. Zhou, B.B. Snider, Org. Lett. 10, 1401-1404 (2008)
24. Q. Zhou, B.B. Snider, J. Org. Chem. 73, 8049-8056 (2008)
25. E. Zeiler, N. Braun, T. Boettcher, A. Kastenmueller, S. Weinkauf, S.A. Sieber, Angew. Chem. Int. Ed. 50, 11001-11004 (2011)
26. A. List, E. Zeiler, N. Gallastegui, M. Rush, C. Hedberg, S.A. Sieber, M. Groll, Angew. Chem. Int. Ed. 53, 571-574 (2014)
27. P.J. Zhao, Y.L. Yang, L. Du, J.K. Liu, Y. Zeng, Angew. Chem. Int. Ed. 52, 2298-2302 (2013)
28. J.H. Kim, H.J. Kim, H.W. Park, S.H. Youn, D.Y. Choi, C.S. Shin, C. S. FEMS Microbiol. Lett. 276, 93-98 (2007)
29. J.A. Dale, H.S. Mosher, J. Am. Chem. Soc. 95, 512-519 (1973)
30. G.R. Sullivan, J.A. Dale, J. Org. Chem. 38, 2143-2147 (1973)
31. H.L. Chen, Y.Q. Feng, Z.S. Xu, T. Ye, Tetrahedron 61, 11132-11140 (2005)
32. R.L. Shen, J. Ma, J. Prog. Vet. Med. 28, 105-108 (2007)
33. Y. Li, Z.H. Liu, J. Li, L. Han, J. Liu, Z.X. Zhao, R.X. Wang, J. Chem. Inf. Model. 54, 1700-1716 (2014)
34. Y. Li, L. Han, Z.H. Liu, R.X. Wang, J. Chem. Inf. Model. 54, 1717-1736 (2014)
35. G. Jones, P. Willett, R.C. Glen, A.R. Leach, A.R. Taylor, R. J. Mol. Biol. 267, 727-748 (1997)
36. M.P. Egloff, F. Marguet, G. Buono, R. Verger, C. Cambillau, H. Tibeurgh, Biochemistry 34, 2751-2762 (1995)

[1]	Jinjuan Wei, Zhe-Xi Li, Gao-Ke Peng, Xinyang Li, He-Ping Chen, Ji-Kai Liu. Vibralactone derivatives isolated from co-cultures of the basidiomycetes Stereum hirsutum and Boreostereum vibrans[J]. 应用天然产物, 2025, 15(2): 20-20.
[2]	Hesham R. El-Seedi, Mohamed S. Refaey, Nizar Elias, Mohamed F. El-Mallah, Faisal M. K. Albaqami, Ismail Dergaa, Ming Du, Mohamed F. Salem, Haroon Elrasheid Tahir, Maria Dagliaa, Nermeen Yosri, Hongcheng Zhang, Awg H. El-Seedi, Zhiming Guo, Shaden A. M. Khalifa. Marine natural products as a source of novel anticancer drugs: an updated review (2019-2023)[J]. 应用天然产物, 2025, 15(2): 13-13.
[3]	María I. Osella, Mario O. Salazar, Carlos M. Solís, Ricardo L. E. Furlan. New semisynthetic α-glucosidase inhibitor from a doubly-chemically engineered extract[J]. 应用天然产物, 2025, 15(1): 4-4.
[4]	Ahmed H. Elbanna, Xinhui Kou, Dilip V. Prajapati, Surasree Rakshit, Rebecca A. Butcher. Discovery of a parallel family of euglenatide analogs in Euglena gracilis[J]. 应用天然产物, 2025, 15(1): 10-10.
[5]	Song-Yu Hou, Bing-Chao Yan, Han-Dong Sun, Pema-Tenzin Puno. Recent advances in the application of [2+2] cycloaddition in the chemical synthesis of cyclobutane-containing natural products[J]. 应用天然产物, 2024, 14(5): 37-37.
[6]	Felaine Anne Sumang, Alan Ward, Jeff Errington, Yousef Dashti. Hibiscus acid and hydroxycitric acid dimethyl esters from Hibiscus flowers induce production of dithiolopyrrolone antibiotics by Streptomyces Strain MBN2-2[J]. 应用天然产物, 2024, 14(5): 40-40.
[7]	Chunsong Hu. Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease[J]. 应用天然产物, 2024, 14(2): 2-2.
[8]	Shohreh Ariaeenejad, Javad Gharechahi, Mehdi Foroozandeh Shahraki, Fereshteh Fallah Atanaki, Jian-Lin Han, Xue-Zhi Ding, Falk Hildebrand, Mohammad Bahram, Kaveh Kavousi, Ghasem Hosseini Salekdeh. Precision enzyme discovery through targeted mining of metagenomic data[J]. 应用天然产物, 2024, 14(1): 7-7.
[9]	Daniel W. Armstrong, Alain Berthod. Occurrence of D-amino acids in natural products[J]. 应用天然产物, 2023, 13(6): 47-47.
[10]	Dalila Carbone, Carmela Gallo, Genoveffa Nuzzo, Giusi Barra, Mario Dell'Isola, Mario Affuso, Olimpia Follero, Federica Albiani, Clementina Sansone, Emiliano Manzo, Giuliana d'Ippolito, Angelo Fontana. Marine natural product lepadin A as a novel inducer of immunogenic cell death via CD91-dependent pathway[J]. 应用天然产物, 2023, 13(5): 34-34.
[11]	Phanankosi Moyo, Luke Invernizzi, Sephora M. Mianda, Wiehan Rudolph, Warren A. Andayi, Mingxun Wang, Neil R. Crouch, Vinesh J. Maharaj. Leveraging off higher plant phylogenetic insights for antiplasmodial drug discovery[J]. 应用天然产物, 2023, 13(5): 35-35.
[12]	Phanankosi Moyo, Luke Invernizzi, Sephora M. Mianda, Wiehan Rudolph, Andrew W. Andayi, Mingxun Wang, Neil R. Crouch, Vinesh J. Maharaj. Prioritised identification of structural classes of natural products from higher plants in the expedition of antimalarial drug discovery[J]. 应用天然产物, 2023, 13(5): 37-37.
[13]	Ji-Kai Liu. Natural products in cosmetics[J]. 应用天然产物, 2022, 12(6): 40-40.
[14]	Si-Yuan Luo, Jun-Yu Zhu, Ming-Feng Zou, Sheng Yin, Gui-Hua Tang. Mulberry Diels–Alder-type adducts: isolation, structure, bioactivity, and synthesis[J]. 应用天然产物, 2022, 12(5): 31-31.
[15]	Yulian Lv, Tian Tian, Yong-Jiang Wang, Jian-Ping Huang, Sheng-Xiong Huang. Advances in chemistry and bioactivity of the genus Erythroxylum[J]. 应用天然产物, 2022, 12(3): 15-15.

Structure-Based Optimization and Biological Evaluation of Pancreatic Lipase Inhibitors as Novel Potential Antiobesity Agents

Structure-Based Optimization and Biological Evaluation of Pancreatic Lipase Inhibitors as Novel Potential Antiobesity Agents

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价